Kerecis
-
Biologics
Kerecis Expands Silicone Fish-Skin Combination Product Range with Shield Spiral, Offering Advanced Customizable Wound Care Solutions
Product offers added benefit of flexible graft tailoring to fit various wound sizes ARLINGTON, Va., July 5, 2024 –(BUSINESS WIRE)–…
Read More » -
Biologics
Medical-Fish-Skin Company Kerecis Expands Silicone Fish-Skin Combination Product Range
Product combines fish-skin grafts and silicone for optimal wound healing environment ARLINGTON, Va. & REYKJAVIK, Iceland, February 16, 2024–(BUSINESS WIRE)–Kerecis,…
Read More » -
Biologics
The wound care biologics market is expected to reach USD 2.26 billion by 2023 from USD 1.42 billion in 2018, at a CAGR of 9.8%
LONDON, June 7, 2018 /PRNewswire/ — The wound care biologics market is projected to grow at a CAGR of 9.8% during the forecast…
Read More » -
Biologics
FDA Clears Omega3-Rich Fish Skin for Surgical Applications
SEPTEMBER 16, 2016 McClean, VA – (Marketwired – Sept 13, 2016) – Kerecis, the company using Omega3-rich fish skin for…
Read More »